Real, industry-grade financial data — verified financials and ClinicalTrials.gov-checked pipelines — turned into institutional-grade research by human analysts, accelerated by AI. Built for serious European biotech investors, across 350+ US & EU tickers.
Our sovereign stack pairs Google Gemini (search-grounded, with live citations) and a second model pinned to verified FMP financials with strict null-handling — so it can't contradict or fabricate the numbers. Then our analysts author the flagship institutional deep-dives by hand in the Claude app (Anthropic Finance plugin), grounded in that same verified data and cross-checked against ClinicalTrials.gov.
Analysts also cite PubMed, peer-reviewed journals and EMA/MHRA sources directly in institutional deep-dives.
Scores sentiment 0–10 across three independent dimensions — Financial, Technological, and Regulatory — then tracks the divergence vs price.
Integrated with Google News (via SerpAPI) and Gemini scoring. We filter noise to deliver only the high-impact Movers: FDA approvals, M&A, trial readouts.
Automated event extraction parses years of history into a clean chronological timeline for every company — kept current.
Illustrative sample of the scored-news feed.
Bloomberg · 2h ago
PR Newswire · 4h ago
Reuters · 6h ago
Endpts · 8h ago
Search 350+ biotech companies across US and EU.
Gemini drafts a search-cited brief in minutes; our analysts then build the institutional 12–15-page deep-dive on verified FMP data.
Post your thesis, vote bull or bear, and shape the consensus score on every ticker.
FDA letters, trial readouts, insider sells — straight to your inbox.
Every figure comes from audited, industry-standard sources and verified filings — never invented by a model. AI just helps us surface and structure it faster. Then our community pressure-tests the thesis: vote bull or bear, set a target price, and steer the consensus score on every ticker.
Join the discussionCommunity-validated upside thesis with cited evidence.
Critical risk analysis — the trade you should reconsider.
Build a track record as the community scores how your calls play out over time.
Paid plans are billed in EUR; VAT is calculated at checkout. Annual billing is two months free. The Free tier stays free during beta — join the waitlist below.
Top-of-funnel · try the platform
or €190/yr · for serious investors
or €990/yr · prosumers & small funds
annual · funds, IR & data teams
Cancel anytime from your profile. Prices in EUR; VAT is calculated at checkout. The Free tier needs no card.
Create your free account for sovereign-AI biotech research, built for serious European investors.
No card · Cancel anytime · Free during beta
Drop your email and we'll send you an invite when subscriptions open. Free tier. No card. Unsubscribe anytime.